Therefore, we considered the presence of HER2 non-determinant of the difference between ER-positive and ER-negative, and we did not use HER2 as a covariate in our analysis, as in other similar studies comparing characteristics between ER-positive and ER-negative BC. This evidence concerns the gene ERBB2 and breast cancer.